<p>This curve shows a higher recurrence rate for those with PCT >0.2 ng/mL but the hazard rate was not significant (HR 1.57, 95% CI 0.7–3.4, <i>P</i> = .246).</p
<p>Kaplan-Meier estimated 3-year recurrence-free survival curves. <b>A:</b> No difference in recurre...
<p>Kaplan-Meier curves of other-cause survival for high ACCI (>3) and low ACCI (≤3) groups (log rank...
<p>In unadjusted analyses, A group level <b>increasing by 1</b> using this index has a hazard ratio ...
<p>Kaplan-Meier curves indicate that there are significant differences in recurrence-free survival b...
<p>Curve 1: 15 patients with score ≤ 2. Curve 2: 17 patients with score ≥ 3. The 14 recurrent patien...
<p>The graphs show recurrence-free survival (A) and overall survival (B) according to the recurrence...
<p>Kaplan-Meier curves for recurrence-free survival rates with urinary tract cancer (A), recurrence-...
<p>The recurrence score of the 17-gene signature predicts poor clinical outcome in lung cancer. The ...
Compared to the Kaplan-Meier curves in Fig 2, this analysis is more meaningful on the IRE technology...
<p>Kaplan-Meier curves showing overall survival and progression free survival probability (above) an...
<p>Kaplan-Meier Curves for major adverse cardiovascular and cerebral events during 1-year follow-up ...
<p>Kaplan-Meier curves on recurrence-free survival (A, B) and overall survival (C, D) according to t...
Kaplan-Meier curves for biochemical recurrence (BCR)-free survival in patients according to residual...
<p>The Kaplan-Meier curve for the cumulative incidences of grade III–IV acute GVHD (A) and chronic G...
<p>Censored Kaplan Meier curve showing the cumulative hazard of relapse over time following discharg...
<p>Kaplan-Meier estimated 3-year recurrence-free survival curves. <b>A:</b> No difference in recurre...
<p>Kaplan-Meier curves of other-cause survival for high ACCI (>3) and low ACCI (≤3) groups (log rank...
<p>In unadjusted analyses, A group level <b>increasing by 1</b> using this index has a hazard ratio ...
<p>Kaplan-Meier curves indicate that there are significant differences in recurrence-free survival b...
<p>Curve 1: 15 patients with score ≤ 2. Curve 2: 17 patients with score ≥ 3. The 14 recurrent patien...
<p>The graphs show recurrence-free survival (A) and overall survival (B) according to the recurrence...
<p>Kaplan-Meier curves for recurrence-free survival rates with urinary tract cancer (A), recurrence-...
<p>The recurrence score of the 17-gene signature predicts poor clinical outcome in lung cancer. The ...
Compared to the Kaplan-Meier curves in Fig 2, this analysis is more meaningful on the IRE technology...
<p>Kaplan-Meier curves showing overall survival and progression free survival probability (above) an...
<p>Kaplan-Meier Curves for major adverse cardiovascular and cerebral events during 1-year follow-up ...
<p>Kaplan-Meier curves on recurrence-free survival (A, B) and overall survival (C, D) according to t...
Kaplan-Meier curves for biochemical recurrence (BCR)-free survival in patients according to residual...
<p>The Kaplan-Meier curve for the cumulative incidences of grade III–IV acute GVHD (A) and chronic G...
<p>Censored Kaplan Meier curve showing the cumulative hazard of relapse over time following discharg...
<p>Kaplan-Meier estimated 3-year recurrence-free survival curves. <b>A:</b> No difference in recurre...
<p>Kaplan-Meier curves of other-cause survival for high ACCI (>3) and low ACCI (≤3) groups (log rank...
<p>In unadjusted analyses, A group level <b>increasing by 1</b> using this index has a hazard ratio ...